- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07598695
Sensory Feedback and Hand Motor Adaptation
May 19, 2026 updated by: The Catholic University of America
Impact of Altered Sensory Feedback on Adaptation of Hand Muscle Coordination of Stroke Survivors
The following experiment will be conducted with 15 chronic stroke survivors and 15 control subjects.
Subjects will perform hand movements in the virtual reality environment using a head-mounted display.
Quest's onboard cameras allow real-time tracking of hand motion, estimating joint angles of the finger and the thumb.
For each feedback manipulation condition (i.e., movement amplification or reduction), the estimated joint angles will be multiplied by a factor greater than 1 (amplification) or a factor smaller than 1 (reduction).
Then the newly-estimated hand posture will be displayed in the VR environment.
Subjects will be randomly assigned into two groups (A and B), who will receive the assistance in a different order.
Subjects will perform finger extension under three conditions: no sensory modulation, movement visual feedback (VF) amplification, and movement VF reduction (error augmentation), while their movement muscle activation patterns are recorded.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
30
Phase
- Early Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Sang Wook Lee, PhD
- Phone Number: 202-319-6218
- Email: leesw@cua.edu
Study Locations
-
-
District of Columbia
-
Washington D.C., District of Columbia, United States, 20064
- Recruiting
- Catholic University of America
-
Contact:
- Sang Wook Lee, PhD
- Phone Number: 312-608-8001
- Email: leesw@cua.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria for stroke group:
- Age: 20 - 70 years old
- First-ever unilateral cortical stroke with resultant hemiparesis at least 6 months prior to the experimental testing
- Fugl-Meyer Upper Extremity Section 31 - 55
Exclusion Criteria for both groups:
- Presence of concurrent severe medical illness
- Pain in hand or arm with movements
- Loss of voluntary control of fingers and thumb
- Inability to provide informed consent
- Musculoskeletal injuries (e.g., fracture) or medical complications (e.g., severe cardiovascular disease).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Visual ROM augmentation followed by visual ROM reduction
|
Finger joint ROM is amplified.
Visual feedback of finger joint ROM is reduced.
|
|
Experimental: Visual ROM reduction followed by visual ROM augmentation
|
Finger joint ROM is amplified.
Visual feedback of finger joint ROM is reduced.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Joint range of motion (ROM)
Time Frame: Periprocedural
|
range of motion of individual finger joints under each condition, measured by embedded cameras that digitize individual finger segments
|
Periprocedural
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Muscle activation
Time Frame: Periprocedural
|
Activation level of hand muscles will be measured using surface EMG electrodes attached to the major hand muscles including extensor digitorum communis, flexor digitorum superficialis, and first dorsal interosseous.
|
Periprocedural
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2025
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
December 31, 2026
Study Registration Dates
First Submitted
May 5, 2026
First Submitted That Met QC Criteria
May 13, 2026
First Posted (Actual)
May 20, 2026
Study Record Updates
Last Update Posted (Actual)
May 22, 2026
Last Update Submitted That Met QC Criteria
May 19, 2026
Last Verified
May 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00006785
- 1R15HD114052 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
The investigators do not plan to share IPD but the de-identified data will be shared.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
University Hospital HeidelbergCompletedAcute Ischemic Stroke | Acute Ischemic Stroke AIS | Acute Ischemic Stroke PatientsGermany
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
Clinical Trials on Visual ROM augmentation
-
Shirley Ryan AbilityLabEnrolling by invitationStroke | Healthy | Stroke, AcuteUnited States
-
Federal University of São PauloCompleted
-
Michael Rapoff, Ph.D.National Institute of Neurological Disorders and Stroke (NINDS)Completed
-
Duzce UniversityCompleted
-
Centers for Disease Control and PreventionUniversity of Colorado, DenverCompleted
-
Necmettin Erbakan UniversityNot yet recruiting
-
Golden Jubilee National HospitalUnknown
-
University of California, DavisLaborie Medical Technologies Inc.Not yet recruitingPregnancy of Unknown Location (PUL)
-
Cairo UniversityRecruiting
-
Universitaire Ziekenhuizen KU LeuvenRecruiting